IRCT2015010319426N4已完成2 期
Assesment the clinical effect of myoinositol on insulin resistence in women with PCOS
Vice chancellor for research, Shahid Beheshti University of Medical Science0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 40 years（—）
- 性别
- Female
入选标准
- •women who were between 20 and 40 years old, and had PCOS diagnosed by a gynecologist.
- •Exclusion criteria: patients who were diagnosed with Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, hypothyroidism, hyperthyroidism, androgen secreting tumor; medications known to affect metabolic parameters, such as metformin and corticosteroids.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Study the effects of pretreatment with myoinositol on oocyte quality in patients with polycyctic ovary syndromepolycystic ovary syndrome disorder.Polycystic ovarian syndromeIRCT2017021432525N2Shahrekord University of Medical Sciences54
尚未招募
3 期
The effect of Myoinositol on the outcomes of assisted reproductive treatments in patients with polycystic ovary syndromeFemale infertility associated with anovulation.Female infertility associated with anovulationN97.0IRCT20240119060732N2Tehran University of Medical Sciences98
已完成
3 期
The effect of myoinositol supplementation on the prevention of gestational diabetes mellitusGestational diabetes mellitus (GDM).O24.4Gestational diabetes mellitusIRCT20120826010664N4Tehran University of Medical Sciences276
进行中（未招募）
不适用
Effect of the combined treatment with myo-inositol and metformin on the phenotype of the polycystic ovary syndrome: a pilot study - UOE/08/03polycystic ovary syndromeMedDRA version: 12.0Level: LLTClassification code 10036049Term: Polycystic ovariesEUCTR2008-006991-31-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
尚未招募
4 期
Effect of a dietary supplement Myo-inositol for treating high sugar levels during pregnancyCTRI/2018/05/013937AIIMS New Delhi